EA200601366A1 - Кристаллическая форма мононатрия ризедроната - Google Patents

Кристаллическая форма мононатрия ризедроната

Info

Publication number
EA200601366A1
EA200601366A1 EA200601366A EA200601366A EA200601366A1 EA 200601366 A1 EA200601366 A1 EA 200601366A1 EA 200601366 A EA200601366 A EA 200601366A EA 200601366 A EA200601366 A EA 200601366A EA 200601366 A1 EA200601366 A1 EA 200601366A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rizedronate
mononatry
crystal form
hydroxyethylidene
pyridyl
Prior art date
Application number
EA200601366A
Other languages
English (en)
Other versions
EA008494B1 (ru
Inventor
Индржих Рихтер
Йосеф Ирман
Original Assignee
Зентива А.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива А.С. filed Critical Зентива А.С.
Publication of EA200601366A1 publication Critical patent/EA200601366A1/ru
Publication of EA008494B1 publication Critical patent/EA008494B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyridine Compounds (AREA)

Abstract

Кристаллическая мононатриевая соль 3-пиридил-1-гидроксиэтилиден-1,1-бисфосфоновой кислоты, имеющая картину дифракции рентгеновских лучей с характеристическими межплоскостными расстояниями 4,35; 8,44; 13,42 и 15,73 ангстрем.
EA200601366A 2004-02-05 2005-02-04 Кристаллическая форма мононатрия ризедроната EA008494B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20040199A CZ298639B6 (cs) 2004-02-05 2004-02-05 Krystalická forma risedronátu monosodného
PCT/CZ2005/000012 WO2005075487A1 (en) 2004-02-05 2005-02-04 Crystalline form of risedronate monosodium

Publications (2)

Publication Number Publication Date
EA200601366A1 true EA200601366A1 (ru) 2006-12-29
EA008494B1 EA008494B1 (ru) 2007-06-29

Family

ID=34832121

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601366A EA008494B1 (ru) 2004-02-05 2005-02-04 Кристаллическая форма мононатрия ризедроната

Country Status (8)

Country Link
EP (1) EP1711507B1 (ru)
AT (1) ATE416182T1 (ru)
CZ (1) CZ298639B6 (ru)
DE (1) DE602005011401D1 (ru)
EA (1) EA008494B1 (ru)
PL (2) PL380526A1 (ru)
UA (1) UA85218C2 (ru)
WO (1) WO2005075487A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83900C2 (en) † 2004-02-26 2008-08-26 ЗЕНТИВА, а.с. Amorphous forms of risedronate monosodium
WO2007042048A2 (en) * 2005-10-11 2007-04-19 Sandoz A/S Method for preparing crystalline sodium risedronate
US8076483B2 (en) 2006-05-11 2011-12-13 M/S. Ind Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
DE102007030370A1 (de) 2007-06-29 2009-01-02 Ratiopharm Gmbh Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728805B1 (fr) * 1994-12-29 1997-03-28 Total Raffinage Distribution Procede et dispositif pour le strippage de solides fluidises et utilisation dans un procede de craquage a l'etat fluide
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PL372964A1 (en) * 2002-04-11 2005-08-08 Teva Pharmaceutical Indudstries, Ltd. Novel polymorphs and pseudopolymorphs of risedronate sodium

Also Published As

Publication number Publication date
EP1711507B1 (en) 2008-12-03
EP1711507A1 (en) 2006-10-18
DE602005011401D1 (de) 2009-01-15
CZ2004199A3 (cs) 2005-09-14
WO2005075487A1 (en) 2005-08-18
PL380526A1 (pl) 2007-02-19
EA008494B1 (ru) 2007-06-29
CZ298639B6 (cs) 2007-12-05
PL1711507T3 (pl) 2009-06-30
UA85218C2 (en) 2009-01-12
ATE416182T1 (de) 2008-12-15

Similar Documents

Publication Publication Date Title
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
BRPI0514372A (pt) inibidores de tiazol de frutose 1, 6-bisfosfatase
RS52274B (en) UNIT DIARYLHIDANTOIN
EA200300107A1 (ru) Кристаллические формы трет-бутиламиновой соли периндоприла
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
NO20081003L (no) 2-Aminopyrimidinderivater som modulatorer av histamin-H4-reseptoraktivitet
RS53599B1 (en) PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS
ATE516291T1 (de) Thenopyrimidin-verbindungen mit fungizider aktivität
WO2007048065A3 (en) Pyrimidinones as casein kinase ii (ck2) modulators
CY1118089T1 (el) Συνθεση υγρου διαπιδυσης η οποια περιλαμβανει ουσιες αναστολης της κρυσταλλωσης
RS52843B (en) THE NEW IS THE HYDROGEN SULPHATE
EA200802213A1 (ru) Способы лечения заболеваний крови
ATE493413T1 (de) Wasserfreie kristalline formen von n-ä1,2- ethoxyethyl)-5-(n-ethyl-n-methylaminoü-7-(4- methylpyridin-2-yl-aminoü-1h-pyrazoloä4,3-
BRPI0414598A (pt) indóis substituìdos
DE602005018653D1 (de) Aktive auswahl der bestätigungsquelle
NO20053483D0 (no) 4-Anilinokinazolinderivater for behandling av unormal cellevekst
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
EA200800324A1 (ru) Новый способ получения солей тиотропия
EA200601438A1 (ru) Аморфные формы мононатриевой соли ризедроновой кислоты
EA200601366A1 (ru) Кристаллическая форма мононатрия ризедроната
CR11368A (es) Forma cristalina 1 de 2- ( (r)-2-metilpirrolidin-2-il) -1h-benzimidazol-4-carboxamida
NO20052994L (no) Nye fosforamidderivater.
PL1845780T3 (pl) Zastosowanie pochodnych metylofenidatu
SE9903290D0 (sv) Novel compounds
DE502006003030D1 (de) Verwendung von inhibitoren des na+/h+ austauschers, subtyp 5 (nhe5) zur gedächtnisverbesserung

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU